15th Congress of the European Hematology Association
WELCOME MESSAGE LIST OF PRESENTATIONS/COURSES OTHER WEBCASTS
Webcasted Presentation
BROWSE: ALL PRESENTATIONS/COURSES SPEAKERS PPT SLIDES VIDEO PODCASTS

Search’n Build™

DASATINIB COMPARED TO IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML-CP): RESULTS FROM THE RANDOMIZED PHASE 3 DASISION TRIA

Prof. Michele Baccarani
Prof. Michele Baccarani
Bologna, Italy  
Disclosure : Bristol-Myers Squibb and Novartis Pharma, research grant, honoraria, consultant
[More] [Less]
Topic: Other
PRE-TEST
PRESENTATION
23 slide(s) – 00:13:21 – English – 2010-06-12
POST-TEST
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
Rate & Comment
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.